The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults-Reference-Cited by-同舟云学术

The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults

Published:2018-06 Issue: Volume:50 Page:11-18
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Darken Patrick,DePetrillo Paolo,Reisner Colin,St Rose Earl^ORCID,Dorinsky Paul

Funder

Pearl – A member of the AstraZeneca Group

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference34 articles.

1. Projections of global mortality and burden of disease from 2002 to 2030;Mathers;PLoS Med.,2006

2. European Lung White Book;European Respiratory Society,2013

3. The clinical and economic burden of chronic obstructive pulmonary disease in the USA;Guarascio;Clinicoecon. Outcomes. Res.,2013

4. Epidemiology and costs of chronic obstructive pulmonary disease;Chapman;Eur. Respir. J.,2006

5. Total and state-specific medical and absenteeism costs of COPD among adults aged >/= 18 years in the United States for 2010 and projections through 2020;Ford;Chest,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous UPLC Assay for Oxitropium Bromide and Formoterol Fumarate Dihydrate in Pressurized Metered Dose Inhaler Products for Chronic Obstructive Pulmonary Disease;Journal of AOAC International;2023-12-18

2. The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly;Contrast Media & Molecular Imaging;2022-08-17

3. Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease;Annals of Pharmacotherapy;2021-08-12

4. Budesonide/Glycopyrronium/Formoterol: A Review in COPD;Drugs;2021-08

5. Recent advances in the development of microparticles for pulmonary administration;Drug Discovery Today;2020-10